Axxam is the famous Corporate Investor, which was founded in 2011. The main department of described Corporate Investor is located in the Milan. The fund was located in Europe if to be more exact in Italy.
The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are KfW, Boehringer Ingelheim Venture Fund. In the next rounds fund is usually obtained by LBBW VC, KfW, Creathor Ventures.
Among the most popular fund investment industries, there are Health Care, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany. Among the most popular portfolio startups of the fund, we may highlight Acousia Therapeutics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The usual things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2016. The fund is generally included in less than 2 deals every year.
Fund Name | Location |
Bushiroad South East Asia Pte Ltd | - |
digital health fund | - |
EaSyndicate | - |
Evolable Asia Japan | Chiyoda, Japan |
French Tech Acceleration Fund | - |
Huaxiang Group | China, Xiangshan, Zhejiang |
Lambda Prime | Boston, Massachusetts, United States |
Manatuck Hill Partners | Connecticut, United States, Westport |
MIT Venture Mentoring Service (MIT VMS) | Cambridge, Massachusetts, United States |
Moodoos Investments | California, San Diego, United States |
National City Equity Partners | Cleveland, Ohio, United States |
NEVEQ | Bulgaria, Grad Sofiya, Sofia |
Private investors | - |
SenaHill Partners | New York, New York, United States |
Shaanxi Huayu Venture Capital | China, Shaanxi, Xian Shi |
Shenzhenshi Dexun Touzi | China, Guangdong, Tianjin |
Trust Tech Japan | Chiyoda, Japan |
Zhengju Capital | China, Chongqing, Chongqing Shi |
Zipcar | Boston, Massachusetts, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
KONTA | $220K | 06 Jul 2021 | Casablanca, Grand Casablanca, Morocco | ||
Acousia Therapeutics | $2M | 14 Dec 2016 | Baden-Württemberg |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
KONTA | $220K | 06 Jul 2021 | Casablanca, Grand Casablanca, Morocco | ||
Acousia Therapeutics | $2M | 14 Dec 2016 | Baden-Württemberg |